D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy

D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy

Positron emission tomography (PET) imaging of the C-X-C chemokine receptor 4 (CXCR4) with [<sup>68</sup>Ga]PentixaFor has intrinsic diagnostic value and is used to select patients for personalized CXCR4-targeted radionuclide therapy with its therapeutic radiopharmaceutical companion [<...

Full description

Bibliographic Details
Main Authors:	Kaat Luyten, Tom Van Loy, Christopher Cawthorne, Christophe M. Deroose, Dominique Schols, Guy Bormans, Frederik Cleeren
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	Pharmaceutics
Subjects:	CXCR4 PET imaging D-peptide-based probe cancer
Online Access:	https://www.mdpi.com/1999-4923/13/10/1619

Similar Items

Synthesis and Anti-HIV Activity of a Novel Series of Isoquinoline-Based CXCR4 Antagonists
by: Mastaneh Safarnejad Shad, et al.
Published: (2021-10-01)

Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
by: Irina Chifu, et al.
Published: (2020-11-01)

Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions
by: Arnaud Boonen, et al.
Published: (2020-10-01)

CXCR4-targeted PET imaging in rheumatoid arthritis: a novel approach for monitoring disease activity and therapeutic response
by: Ya Han, et al.
Published: (2025-02-01)

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside
by: Stephen Ahenkorah, et al.
Published: (2021-04-01)

Exploration of Pyrido[3,4-<i>d</i>]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2
by: Max Van Hoof, et al.
Published: (2023-02-01)

CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response
by: Delaine K. Ceholski, et al.
Published: (2017-08-01)

Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization
by: Katrijn Boon, et al.
Published: (2024-01-01)

The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases
by: Rojin Sarallah, et al.
Published: (2025-02-01)

High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma
by: Wang Linhui, et al.
Published: (2012-10-01)

Current Status of <sup>68</sup>Ga-Pentixafor in Solid Tumours
by: Bawinile Hadebe, et al.
Published: (2022-09-01)

Automated synthesis and quality control of [68Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imaging
by: Thomas Daniel, et al.
Published: (2023-02-01)

Chemokine Receptor-4 Targeted PET/CT Imaging with <sup>68</sup>Ga-Pentixafor in Head and Neck Cancer—A Comparison with <sup>18</sup>F-FDG and CXCR4 Immunohistochemistry
by: Bawinile Hadebe, et al.
Published: (2024-06-01)

Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models
by: Lucas A. Horn, et al.
Published: (2024-12-01)

Genetic association of polymorphism rs2230054 in CXCR2 gene with gout in Chinese Han male population
by: Yangang Wang, et al.
Published: (2020-04-01)

CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
by: Wu Xia, et al.
Published: (2023-08-01)

Self-assembly of CXCR4 antagonist peptide–docetaxel conjugates for breast tumor multi-organ metastasis inhibition
by: Chen Li, et al.
Published: (2023-09-01)

The role of CXCR3 and its ligands in cancer
by: Xiaoming Wang, et al.
Published: (2022-11-01)

Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022)
by: Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group, et al.
Published: (2022-11-01)

The value of targeted CXCR4 18F-AlF-NOTA-pentixafor PET/CT for subtyping primary aldosteronism
by: Yushi Peng, et al.
Published: (2025-02-01)

Rigid Macrocycle Metal Complexes as CXCR4 Chemokine Receptor Antagonists: Influence of Ring Size
by: Isaline Renard, et al.
Published: (2024-07-01)

Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice
by: Larissa Fonseca da Cunha Sousa, et al.
Published: (2013-01-01)

FLUORESCENT PROBES FOR INVESTIGATION PEPTIDE NATURE SUBSTANCES IN THE CRYOPRESERVED ORGANS FRAGMENTS EXTRACTS
by: L. A. Rohoza, et al.
Published: (2013-10-01)

Synthesis and preclinical evaluation of a novel fluorine-18 labeled small-molecule PET radiotracer for imaging of CXCR3 receptor in mouse models of atherosclerosis
by: Santosh R. Alluri, et al.
Published: (2023-07-01)

Sulfated CXCR3 Peptide Trap Use as a Promising Therapeutic Approach for Age-Related Macular Degeneration
by: Gukheui Jo, et al.
Published: (2024-01-01)

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2
by: Martin Mangold, et al.
Published: (2018-05-01)

Imaging Inflammation in Atherosclerosis with CXCR4-Directed [<sup>68</sup>Ga]PentixaFor PET/MRI—Compared with [<sup>18</sup>F]FDG PET/MRI
by: Xia Lu, et al.
Published: (2022-07-01)

Discovery of Highly Potent and Selective CXCR4 Inhibitors Using Protein Epitope Mimetics (PEM) Technology
by: Alexander Lederer, et al.
Published: (2007-04-01)

CXCR3-Expressing T Cells in Infections and Autoimmunity
by: Artem Rubinstein, et al.
Published: (2024-08-01)

Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significance
by: Yunfu Lv, et al.
Published: (2023-08-01)

The chemokine receptor CXCR4 is associated with the staging of gastric cancer
by: Mehrnoush Nikzaban, et al.
Published: (2014-01-01)

Expression of the chemokine receptor CXCR4 on lymphocytes of leprosy patients
by: V.A. Mendonça, et al.
Published: (2011-12-01)

The importance of the CXCL12/CXCR4 axis in therapeutic approaches to Diabetes mellitus attenuation
by: Melita eVidakovic, et al.
Published: (2015-08-01)

Modulatory effects of trophoblast-secreted CXCL12 on the migration and invasion of human first-trimester decidual epithelial cells are mediated by CXCR4 rather than CXCR7
by: Jiayi Zheng, et al.
Published: (2018-03-01)

New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM
by: Stefania Scala, et al.
Published: (2020-04-01)

Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurements.
by: Jordi Doijen, et al.
Published: (2017-01-01)

CXCR4 Recognition by L- and D-Peptides Containing the Full-Length V3 Loop of HIV-1 gp120
by: Ruohan Zhu, et al.
Published: (2023-04-01)

Intratumoral CXCR4hi neutrophils display ferroptotic and immunosuppressive signatures in hepatoblastoma
by: Zhengjing Lu, et al.
Published: (2024-02-01)

Dichotomous Roles of Programmed Cell Death 1 on HIV-Specific CXCR5+ and CXCR5− CD8+ T Cells during Chronic HIV Infection
by: Yan-Mei Jiao, et al.
Published: (2017-12-01)

NHS-Functionalized THP Derivative for Efficient Synthesis of Kit-Based Precursors for <sup>68</sup>Ga Labeled PET Probes
by: Giuseppe Floresta, et al.
Published: (2021-04-01)